Lenalidomide Catalog No.:M8013-2 5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-[1

5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-[1

34(3):360-6

with reduced or absent effect for X4-tropic laboratory isolates

thus inhibiting the translation of peptides

Filipczak PT

Lenalidomide Catalog No.:M8013-2 5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-[1Lenalidomide, also known as CC 5013, is the thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. Lenalidomide is an approved drug. Product information CAS